• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高迁移率族蛋白 B1(HMGB1)作为癫痫发生的新前沿:从发病机制到治疗方法。

High mobility group box 1 (HMGB1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches.

机构信息

Neuropharmacology Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.

Department of Neuroscience, Central Clinical School, Monash University, The Alfred Hospital, Melbourne, Australia.

出版信息

J Neurochem. 2019 Dec;151(5):542-557. doi: 10.1111/jnc.14663. Epub 2019 Feb 12.

DOI:10.1111/jnc.14663
PMID:30644560
Abstract

Epilepsy is a serious neurological condition exhibiting complex pathology and deserving of more serious attention. More than 30% of people with epilepsy are not responsive to more than 20 anti-epileptic drugs currently available, reflecting an unmet clinical need for novel therapeutic strategies. Not much is known about the pathogenesis of epilepsy, but evidence indicates that neuroinflammation might contribute to the onset and progression of epilepsy following acquired brain insults. However, the molecular mechanisms underlying these pathophysiological processes are yet to be fully understood. The emerging research suggests that high-mobility group box protein 1 (HMGB1), a DNA-binding protein that is both actively secreted by inflammatory cells and released by necrotic cells, might contribute to the pathogenesis of epilepsy. HMGB1 as an initiator and amplifier of neuroinflammation, and its activation is implicated in the propagation of seizures in animal models. The current review will highlight the potential role of HMGB1 in the pathogenesis of epilepsy, and implications of HMGB1-targeted therapies against epilepsy. HMGB1 in this context is an emerging concept deserving further exploration. Increased understanding of HMGB1 in seizures and epilepsy will pave the way in designing novel and innovative therapeutic strategies that could modify the disease course or prevent its development.

摘要

癫痫是一种严重的神经系统疾病,具有复杂的病理,值得给予更认真的关注。目前有超过 30%的癫痫患者对 20 多种现有抗癫痫药物没有反应,这反映了临床上对新型治疗策略的需求尚未得到满足。对于癫痫的发病机制了解甚少,但有证据表明,神经炎症可能导致获得性脑损伤后癫痫的发作和进展。然而,这些病理生理过程的分子机制尚未完全理解。新出现的研究表明,高迁移率族蛋白 B1(HMGB1)可能与癫痫的发病机制有关。HMGB1 是一种 DNA 结合蛋白,既能被炎症细胞主动分泌,也能由坏死细胞释放,它是神经炎症的启动子和放大器,其激活与动物模型中癫痫发作的传播有关。本综述将重点介绍 HMGB1 在癫痫发病机制中的潜在作用,以及针对癫痫的 HMGB1 靶向治疗的意义。在这种情况下,HMGB1 是一个新兴概念,值得进一步探索。增加对 HMGB1 在癫痫发作和癫痫中的理解,将为设计新型创新治疗策略铺平道路,这些策略可能改变疾病进程或预防其发展。

相似文献

1
High mobility group box 1 (HMGB1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches.高迁移率族蛋白 B1(HMGB1)作为癫痫发生的新前沿:从发病机制到治疗方法。
J Neurochem. 2019 Dec;151(5):542-557. doi: 10.1111/jnc.14663. Epub 2019 Feb 12.
2
High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.高迁移率族蛋白 B1 是癫痫的一种新型致病因子和机制性生物标志物。
Brain Behav Immun. 2018 Aug;72:14-21. doi: 10.1016/j.bbi.2017.10.008. Epub 2017 Oct 13.
3
High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches.高迁移率族蛋白 1 在帕金森病中的作用:从发病机制到治疗方法。
J Neurochem. 2018 Aug;146(3):211-218. doi: 10.1111/jnc.14450. Epub 2018 Jul 3.
4
Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy.高迁移率族蛋白盒1的分子亚型是癫痫的机制性生物标志物。
J Clin Invest. 2017 Jun 1;127(6):2118-2132. doi: 10.1172/JCI92001. Epub 2017 May 15.
5
Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.针对氧化应激可改善获得性癫痫大鼠模型的疾病转归。
Brain. 2017 Jul 1;140(7):1885-1899. doi: 10.1093/brain/awx117.
6
Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.晚期糖基化终产物受体在颞叶癫痫中上调,并促进实验性癫痫发作。
Neurobiol Dis. 2013 Oct;58:102-14. doi: 10.1016/j.nbd.2013.03.006. Epub 2013 Mar 21.
7
The Potential Therapeutic Role of the HMGB1-TLR Pathway in Epilepsy.HMGB1-TLR 通路在癫痫中的潜在治疗作用。
Curr Drug Targets. 2021;22(2):171-182. doi: 10.2174/1389450121999200729150443.
8
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction.高迁移率族蛋白B1:创伤性脑损伤、神经炎症、癫痫及认知功能障碍的常见生物标志物和潜在靶点
Front Neurosci. 2018 Sep 11;12:628. doi: 10.3389/fnins.2018.00628. eCollection 2018.
9
Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics.抗高迁移率族蛋白1单克隆抗体下调P-糖蛋白作为新型癫痫治疗药物
Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):121. doi: 10.1186/s41983-022-00557-8. Epub 2022 Oct 22.
10
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.揭示高迁移率族蛋白 B1(HMGB1)在炎症中的作用:受体信号转导的最新进展。
Eur J Pharmacol. 2019 Sep 5;858:172487. doi: 10.1016/j.ejphar.2019.172487. Epub 2019 Jun 20.

引用本文的文献

1
Repurposing Saroglitazar for neurodegenerative disorders: insight into molecular signalling pathways and neuroprotective modulations.将沙罗格列扎重新用于治疗神经退行性疾病:对分子信号通路和神经保护调节的深入了解。
Inflammopharmacology. 2025 Jun 23. doi: 10.1007/s10787-025-01805-y.
2
HMGB1 mediates inflammation response of epileptogenicity in tuberous sclerosis complex-related epilepsy.高迁移率族蛋白B1介导结节性硬化症相关癫痫中致痫性的炎症反应。
Sci Prog. 2025 Apr-Jun;108(2):368504251338653. doi: 10.1177/00368504251338653. Epub 2025 Jun 12.
3
Evaluation of the covariation between leukotriene B4, prostaglandin E2, and hematologic inflammatory parameters in a canine pentylenetetrazole-induced seizure model.
犬戊四氮诱导癫痫模型中白三烯B4、前列腺素E2与血液学炎症参数之间协变关系的评估。
Front Neurosci. 2024 Dec 11;18:1451902. doi: 10.3389/fnins.2024.1451902. eCollection 2024.
4
A Systematic Review of the Predictive and Diagnostic Uses of Neuroinflammation Biomarkers for Epileptogenesis.神经炎症生物标志物在癫痫发生中的预测和诊断作用的系统评价。
Int J Mol Sci. 2024 Jun 12;25(12):6488. doi: 10.3390/ijms25126488.
5
High mobility group box 1 in the central nervous system: regeneration hidden beneath inflammation.中枢神经系统中的高迁移率族蛋白盒1:炎症掩盖下的再生
Neural Regen Res. 2025 Jan 1;20(1):107-115. doi: 10.4103/NRR.NRR-D-23-01964. Epub 2024 Apr 3.
6
Circulating HMGB1 in acute ischemic stroke and its association with post-stroke cognitive impairment.急性缺血性脑卒中患者循环 HMGB1 及其与卒中后认知障碍的关系。
PeerJ. 2024 Apr 30;12:e17309. doi: 10.7717/peerj.17309. eCollection 2024.
7
Conduction treatment of temporal lobe epilepsy in rats: the dose-effect relationship between current resistance and therapeutic effect.大鼠颞叶癫痫的电传导治疗:电流电阻与治疗效果之间的剂量效应关系。
Front Neurol. 2023 May 25;14:1181953. doi: 10.3389/fneur.2023.1181953. eCollection 2023.
8
Inflachromene attenuates seizure severity in mouse epilepsy models via inhibiting HMGB1 translocation.Infachromene 通过抑制 HMGB1 易位来减轻小鼠癫痫模型中的癫痫严重程度。
Acta Pharmacol Sin. 2023 Sep;44(9):1737-1747. doi: 10.1038/s41401-023-01087-6. Epub 2023 Apr 19.
9
A Comprehensive Review on Anti-Inflammatory Response of Flavonoids in Experimentally-Induced Epileptic Seizures.黄酮类化合物在实验性癫痫发作中抗炎反应的综合综述
Brain Sci. 2023 Jan 5;13(1):102. doi: 10.3390/brainsci13010102.
10
Glycyrrhizin regulates the HMGB1/P38MAPK signalling pathway in status epilepticus.甘草酸通过调控 HMGB1/P38MAPK 信号通路在癫痫持续状态中发挥作用。
Mol Med Rep. 2023 Feb;27(2). doi: 10.3892/mmr.2023.12932. Epub 2023 Jan 12.